4.6 Article

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders

Journal

MOVEMENT DISORDERS
Volume 35, Issue 5, Pages 711-715

Publisher

WILEY
DOI: 10.1002/mds.28067

Keywords

-

Funding

  1. NIH-NINDS [NS45962, NS073994, NS110416]
  2. NIH-NINDS (NCRR) [RR000165]
  3. NIH-NINDS (ORIP/OD) [OD011132]
  4. Forum Pharmaceuticals, Inc.
  5. Mochida Pharmaceuticals Co. LTD
  6. Circuit Therapeutics, Inc.
  7. Michael J. Fox Foundation
  8. AbbVie
  9. Merz
  10. Allergan
  11. Cavion
  12. Ipsen
  13. Praxis
  14. Seqirus
  15. Stada
  16. Teva
  17. UCB
  18. Alfasigma
  19. BIAL
  20. Zambon

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available